Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Rev Fr Gynecol Obstet ; 84(1): 41-3, 1989 Jan.
Article in French | MEDLINE | ID: mdl-2538912

ABSTRACT

In this paper, the authors present a case of phyllodes tumor whose original interest lies in its association with an in situ lobular carcinoma. The authors present the clinical, radiological, and anatomopathological characteristics of these cases. Finally, they discuss the therapeutic management in light of data from the literature.


Subject(s)
Breast Neoplasms/pathology , Carcinoma in Situ/pathology , Neoplasms, Multiple Primary/pathology , Phyllodes Tumor/pathology , Adult , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/surgery , Carcinoma in Situ/surgery , Female , Humans , Mammography , Neoplasms, Multiple Primary/surgery , Phyllodes Tumor/diagnostic imaging , Phyllodes Tumor/surgery
2.
Rev Fr Gynecol Obstet ; 82(5): 355-9, 1987 May.
Article in French | MEDLINE | ID: mdl-3299650

ABSTRACT

A case of treatment of an advanced ovarian adenocarcinoma (Stage IIIc of the FIGO) is reported. The patient underwent a maximal tumor reduction followed with polychemotherapy. After this treatment, a "second look" laparotomy shows an incomplete remission. An intensive chemotherapy with abdomini-pelvic radiotherapy and protection of medullary toxicity by a bone marrow autograft is performed, with a satisfactory result, without relapse, 16 months after this treatment (or 25 months after the first laparotomy). A review of the literature concerning the treatment to be undertaken following the "second look" operation, is briefly exposed. Reasons which led the authors to perform an autograft and mostly the conditions under which this treatment may be offered, are then presented.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow Transplantation , Cystadenocarcinoma/therapy , Ovarian Neoplasms/therapy , Adult , Combined Modality Therapy , Cystadenocarcinoma/drug therapy , Cystadenocarcinoma/pathology , Drug Administration Schedule , Female , Humans , Neoplasm Staging , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...